Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients

The receptor activator of NF-κB (RANK) pathway is involved in bone health as well as breast cancer (BC) pathogenesis and progression. Whereas the therapeutic implication of this pathway is established for the treatment of osteoporosis and bone metastases, the application in adjuvant BC is currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Hein, Alexander, Bayer, Christian M., Schrauder, Michael G., Häberle, Lothar, Heusinger, Katharina, Strick, Reiner, Ruebner, Matthias, Lux, Michael P., Renner, Stefan P., Schulz-Wendtland, Rüdiger, Ekici, Arif B., Hartmann, Arndt, Beckmann, Matthias W., Fasching, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963378/
https://www.ncbi.nlm.nih.gov/pubmed/24729980
http://dx.doi.org/10.1155/2014/842452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963378/
https://www.ncbi.nlm.nih.gov/pubmed/24729980
http://dx.doi.org/10.1155/2014/842452

Ejemplares similares